As Head of Global Rare Diseases at the Chiesi Group, Giacomo leads the team in developing, and commercializing treatments for rare and ultra-rare disease. Before joining the family business, he was a consultant with Bain and Co. and Accenture. Since then, he's expanded the Chiesi Group presence in the US and EU and established a global portfolio and pipelines in rare diseases.
Fabry disease can be seriously debilitating, and its complications strongly impair patients' quality of life and daily activities. We often find that mental health challenges are associated with many rare and chronic diseases like Fabry disease. We are grateful for the opportunity to partner with NAMI, an organization that shares our commitment to deliver solutions that can help these underserved communities.
/PRNewswire/ -- Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people affected...